Dr. Leonard Valentino, M.D

NPI: 1952336208
Total Payments
$117,453
2024 Payments
$34,332
Companies
8
Transactions
109

Payment Breakdown by Category

Consulting$83,938 (71.5%)
Other$24,950 (21.2%)
Travel$5,030 (4.3%)
Food & Beverage$3,524 (3.0%)
Gifts$11.96 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $83,938 28 71.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,800 4 15.2%
Honoraria $7,150 1 6.1%
Travel and Lodging $5,030 26 4.3%
Food and Beverage $3,524 46 3.0%
Gift $11.96 4 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $40,592 19 $0 (2024)
HEMA Biologics, LLC $40,528 62 $0 (2024)
BioMarin Pharmaceutical Inc. $11,302 4 $0 (2024)
GENZYME CORPORATION $9,922 1 $0 (2024)
CSL Behring $9,100 1 $0 (2022)
Regeneron Pharmaceuticals, Inc. $3,524 3 $0 (2024)
Novartis Pharmaceuticals Corporation $1,810 11 $0 (2024)
Spark Therapeutics, Inc. $675.72 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $34,332 24 GENZYME CORPORATION ($9,922)
2023 $21,944 34 HEMA Biologics, LLC ($15,202)
2022 $30,353 35 HEMA Biologics, LLC ($20,814)
2021 $22,625 13 Takeda Pharmaceuticals U.S.A., Inc. ($19,500)
2020 $8,198 3 Takeda Pharmaceuticals U.S.A., Inc. ($8,100)

All Payment Transactions

109 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
12/31/2024 BioMarin Pharmaceutical Inc. Consulting Fee Cash or cash equivalent $2,967.18 General
11/25/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $840.00 General
11/21/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $820.00 General
07/11/2024 HEMA Biologics, LLC SevenFact (Biological) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: Hematology
05/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ADYNOVATE (Biological) Consulting Fee Cash or cash equivalent $1,890.00 General
Category: HEMATOLOGY
04/26/2024 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,762.00 General
03/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ADYNOVATE (Biological) Food and Beverage In-kind items and services $84.60 General
Category: HEMATOLOGY
03/22/2024 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $881.00 General
03/22/2024 Regeneron Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $881.00 General
03/18/2024 GENZYME CORPORATION Consulting Fee Cash or cash equivalent $9,922.00 General
03/18/2024 Takeda Pharmaceuticals U.S.A., Inc. ADYNOVATE (Biological) Consulting Fee Cash or cash equivalent $5,040.00 General
Category: HEMATOLOGY
03/14/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $60.00 General
Category: Immunology
03/14/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $45.14 General
Category: Immunology
03/14/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $24.35 General
Category: Immunology
03/13/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $191.49 General
Category: Immunology
03/13/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $63.84 General
Category: Immunology
03/13/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $12.72 General
Category: Immunology
03/12/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $744.42 General
Category: Immunology
03/12/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $552.20 General
Category: Immunology
03/12/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $53.00 General
Category: Immunology
03/12/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $35.89 General
Category: Immunology
03/12/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Travel and Lodging In-kind items and services $26.56 General
Category: Immunology
12/18/2023 Takeda Pharmaceuticals U.S.A., Inc. ADYNOVATE (Biological) Consulting Fee Cash or cash equivalent $4,200.00 General
Category: HEMATOLOGY

About Dr. Leonard Valentino, M.D

Dr. Leonard Valentino, M.D is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952336208.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Valentino, M.D has received a total of $117,453 in payments from pharmaceutical and medical device companies, with $34,332 received in 2024. These payments were reported across 109 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($83,938).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Chicago, IL
  • Active Since 07/12/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1952336208

Products in Payments

  • SevenFact (Biological) $40,447
  • ADYNOVATE (Biological) $11,317
  • VONVENDI (Biological) $10,365
  • ADVATE (Biological) $2,500
  • Fabhalta (Drug) $1,810

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Chicago